Back to GetFilings.com



Table of Contents



SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q


     
[X]   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
    SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended February 1, 2004 or

     
[   ]   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

For the transition period from                to                .

0-21488

(Commission File Number)


CATALYST SEMICONDUCTOR, INC.

(Exact name of Registrant as specified in its charter)


     
Delaware
(State or other jurisdiction of
incorporation or organization)
  77-0083129
(I.R.S. Employer
Identification No.)
     
1250 Borregas Avenue
Sunnyvale, California

(Address of Registrant’s principal executive offices)
  94089
(Zip Code)

(408) 542-1000

(Registrant’s telephone number, including area code)

     Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

     Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12(b)(2) of the Exchange Act). Yes x No o

     The number of shares outstanding of the Registrant’s Common Stock as of February 13, 2004 was 16,703,114 exclusive of 3,044,100 shares of treasury stock.



 


TABLE OF CONTENTS

PART I – FINANCIAL INFORMATION
Item 1. Consolidated Financial Statements
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Item 4. Controls and Procedures
PART II OTHER INFORMATION
Item 1. Legal Proceedings
Item 6. Exhibits and Reports on Form 8-K
SIGNATURES
INDEX TO EXHIBITS
EXHIBIT 10.1
EXHIBIT 31.1
EXHIBIT 31.2
EXHIBIT 32


Table of Contents

CATALYST SEMICONDUCTOR, INC.

TABLE OF CONTENTS

         
        Page
       
PART I.
 
FINANCIAL INFORMATION
 
Item 1.
 
Consolidated Financial Statements
 
 
 
Unaudited Condensed Consolidated Balance Sheets at January 31, 2004 and April 30, 2003
 
  3
 
 
Unaudited Condensed Consolidated Statements of Operations for the three and nine month periods ended January 31, 2004 and 2003
 
  4
 
 
Unaudited Condensed Consolidated Statements of Cash Flows for the nine month periods ended January 31, 2004 and 2003
 
  5
 
 
Notes to Unaudited Condensed Consolidated Financial Statements
 
  6
Item 2.
 
Management’s Discussion and Analysis of Financial Condition and Results of Operations
 
13
Item 3.
 
Quantitative and Qualitative Disclosures About Market Risk
 
29
Item 4.
 
Controls and Procedures
 
29
PART II.
 
OTHER INFORMATION
 
Item 1.
 
Legal Proceedings
 
30
Item 4.
 
Submission of Matters to a Vote of Security Holder
 
30
Item 6.
 
Exhibits and Reports on Form 8-K
 
30
SIGNATURES
 
 
 
31
EXHIBIT INDEX
 
 
 
32
CERTIFICATIONS
 
 
 
33-35

2


Table of Contents

PART I – FINANCIAL INFORMATION

Item 1. Consolidated Financial Statements

CATALYST SEMICONDUCTOR, INC.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)

                         
            January 31,   April 30,
            2004   2003
           
 
       
ASSETS
               
Current assets:
               
 
Cash and cash equivalents
  $ 18,604     $ 7,828  
 
Short term investments
    16,247       20,078  
 
Accounts receivable, net
    10,275       7,863  
 
Inventories, net
    6,876       8,423  
 
Deferred tax assets
    1,914       1,914  
 
Other assets
    844       1,146  
 
   
     
 
   
Total current assets
    54,760       47,252  
Property and equipment, net
    3,022       3,091  
Other assets
    271       245  
 
   
     
 
   
Total assets
  $ 58,053     $ 50,588  
 
   
     
 
     
LIABILITIES AND STOCKHOLDERS’ EQUITY
               
Current liabilities:
               
 
Accounts payable
  $ 4,485     $ 3,674  
 
Accounts payable—related party
    429       18  
 
Accrued expenses
    3,623       3,126  
 
Deferred gross profit on shipments to distributors
    2,614       1,417  
 
   
     
 
   
Total current liabilities
    11,151       8,235  
 
   
     
 
Commitments and Contingencies (Note 8)
               
Stockholders’ equity:
               
 
Preferred stock, $.001 par value, 2,000 shares authorized; no shares issued or outstanding
           
 
Common stock, $.001 par value, 45,000 shares authorized; 19,739 issued and 16,695 outstanding at January 31, 2004 and 19,247 shares issued and 16,285 outstanding at April 30, 2003
    20       19  
 
Additional paid in capital
    53,644       52,632  
 
Treasury stock, 3,044 at January 31, 2004 and 2,962 at April 30, 2003
    (8,555 )     (8,340 )
 
Retained earnings (Accumulated deficit)
    1,782       (1,985 )
 
Accumulated other comprehensive income
    11       27  
 
   
     
 
   
Total stockholders’ equity
    46,902       42,353  
 
   
     
 
   
Total liabilities and stockholders’ equity
  $ 58,053     $ 50,588  
 
   
     
 

See accompanying notes to the unaudited condensed consolidated financial statements.

3


Table of Contents

CATALYST SEMICONDUCTOR, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)

                                   
      Three Months Ended   Nine Months Ended
     
 
      January 31,   January 31,   January 31,   January 31,
      2004   2003   2004   2003
     
 
 
 
Net revenues
  $ 16,875     $ 11,207     $ 46,700     $ 35,711  
Cost of revenues
    9,108       7,089       28,795       21,182  
 
   
     
     
     
 
Gross profit
    7,767       4,118       17,905       14,529  
Research and development
    1,936       1,269       5,134       3,753  
Selling, general and administrative
    2,984       2,451       8,515       7,333  
 
   
     
     
     
 
Income from operations
    2,847       398       4,256       3,443  
Interest income, net
    108       83       282       237  
 
   
     
     
     
 
Income before income taxes
    2,955       481       4,538       3,680  
Income tax provision
    534       167       771       1,363  
 
   
     
     
     
 
Net income
  $ 2,421     $ 314     $ 3,767     $ 2,317  
 
   
     
     
     
 
Net income per share:
                               
 
Basic
  $ 0.15     $ 0.02     $ 0.23     $ 0.14  
 
   
     
     
     
 
 
Diluted
  $ 0.12     $ 0.02     $ 0.19     $ 0.13  
 
   
     
     
     
 
Weighted average common shares:
                               
 
Basic
    16,620       16,774       16,487       16,813  
 
   
     
     
     
 
 
Diluted
    19,890       18,176       19,351       18,492  
 
   
     
     
     
 

See accompanying notes to the unaudited condensed consolidated financial statements.

4


Table of Contents

CATALYST SEMICONDUCTOR, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)

                         
            Nine Months Ended
           
            January 31,   January 31,
            2004   2003
           
 
Cash flows from operating activities:
               
 
Net income
  $ 3,767     $ 2,317  
 
Adjustments to reconcile net income to net cash provided by operating activities:
               
   
Depreciation of property and equipment
    1,049       787  
   
Benefit from sale of inventory previously reserved
    (1,583 )     (2,237 )
   
Provision for excess and obsolete inventory
    705       2,181  
   
Loss on the sale of fixed assets
    28       11  
   
Changes in assets and liabilities:
               
     
Accounts receivable
    (2,412 )     1,486  
     
Inventories
    2,425       892  
     
Other assets
    276       517  
     
Accounts payable (including related party)
    1,222       (777 )
     
Accrued expenses
    663       1,070  
     
Deferred gross profit on shipments to distributors
    1,197       (184 )
 
   
     
 
       
Net cash provided by operating activities
    7,337       6,063  
 
   
     
 
Cash flows from investing activities:
               
 
Sale (purchase) of short-term investments
    3,815       (7,964 )
 
Acquisition of property and equipment
    (1,008 )     (1,044 )
 
   
     
 
       
Net cash provided by (used in) investing activities
    2,807       (9,008 )
 
   
     
 
Cash flows from financing activities:
               
 
Common stock issuances
    847       227  
 
Treasury stock purchases
    (215 )     (1,659 )
 
   
     
 
       
Net cash provided by (used in) financing activities
    632       (1,432 )
 
   
     
 
Net increase (decrease) in cash and cash equivalents
    10,776       (4,377 )
Cash and cash equivalents at beginning of the period
    7,828       26,295  
 
   
     
 
Cash and cash equivalents at end of the period
  $ 18,604     $ 21,918  
 
   
     
 

See accompanying notes to the unaudited condensed consolidated financial statements.

5


Table of Contents

CATALYST SEMICONDUCTOR, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note 1 - Basis of Presentation:

     In the opinion of the management of Catalyst Semiconductor, Inc. (Company), the unaudited condensed consolidated interim financial statements included herein have been prepared on the same basis as the Company’s April 30, 2003 audited consolidated financial statements and include all adjustments, consisting of only normal recurring adjustments, necessary to fairly state the information set forth herein. The consolidated statements include the accounts of the Company’s wholly owned subsidiaries, Nippon Catalyst KK (NCKK), a sales organization in Japan and Catalyst Semiconductor Romania SRL (CSR), a design center in Europe. All material intercompany balances have been eliminated. The statements have been prepared in accordance with the regulations of the Securities and Exchange Commission (SEC). For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended April 30, 2003. The results of operations for the three and nine month periods ended January 31, 2004 are not necessarily indicative of the results to be expected for the entire year ending April 30, 2004 or any other future period. Certain prior period balances have been reclassified to conform to the current period presentation.

     The Company’s business is highly cyclical and has been subject to significant downturns at various times which have been characterized by reduced product demand, production overcapacity and significant erosion of average selling prices.

     Occasionally, periods of significant upturns occur during which foundry capacity is limited resulting in shortages and increased inventory costs.

     The Company’s fiscal year is the 52 or 53-week period ending on the Sunday closest to April 30. In a 52-week year, each fiscal quarter consists of 13 weeks. Fiscal year 2004 will be comprised of 53 weeks with the extra week added to the third quarter making it consist of 14 weeks. For presentation purposes only, the financial statements and notes refer to April 30 as the Company’s year-end and July 31, October 31 and January 31 as the Company’s quarter-ends.

     In December 2002, the Financial Accounting Standards Board (FASB) issued Statement of Financial Accounting Standards (SFAS) No. 148, “Accounting for Stock-Based Compensation, Transition and Disclosure” which amended SFAS No. 123 (SFAS 123) requiring that disclosures of the pro forma effect use the fair value method of accounting for stock-based employee compensation be displayed more prominently, in a tabular format and on a quarterly basis. The following table illustrates the effect on the Company’s net income and net income per share if compensation costs had been recorded based on the estimated fair value as of the grant date as defined by SFAS 123 for all granted stock-based awards.

                                 
    Three Months Ended   Nine Months Ended
   
 
    January 31,   January 31,   January 31,   January 31,
    2004   2003   2004   2003
   
 
 
 
    (In thousands, except per share amounts)
Reported net income
  $ 2,421     $ 314     $ 3,767     $ 2,317  
Add: Stock-based employee compensation expense included in reported net income, net of tax
          10             57  
Deduct: Stock-based employee compensation expense determined under fair value based method for all awards, net of tax
    (1,012 )     (640 )     (2,443 )     (2,000 )
 
   
     
     
     
 
Pro forma net income (loss)
  $ 1,409     $ (316 )   $ 1,324     $ 374  
 
   
     
     
     
 
Pro forma net income (loss) per share:
                               
Basic
  $ 0.08     $ (0.02 )   $ 0.08     $ 0.02  
 
   
     
     
     
 
Diluted
  $ 0.07     $ (0.02 )   $ 0.07     $ 0.02  
 
   
     
     
     
 

6


Table of Contents

CATALYST SEMICONDUCTOR, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note 2 – Net Income Per Share:

     Basic net income per share is computed by dividing net income available to common stockholders (numerator) by the weighted average number of common shares outstanding (denominator) during the period and excludes the dilutive effect of stock options. Diluted net income per share gives effect to all dilutive potential common shares outstanding during a period. In computing diluted net income per share, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options.

     A reconciliation of the numerators and denominators of the basic and diluted income per share is presented in the following table (in thousands, except per share data):

                                 
    Three Months Ended   Nine Months Ended
   
 
    January 31,   January 31,   January 31,   January 31,
    2004   2003   2004   2003
   
 
 
 
Reported net income
  $ 2,421     $ 314     $ 3,767     $ 2,317  
 
   
     
     
     
 
Shares calculation:
                               
Weighted average shares outstanding—basic
    16,620       16,774       16,487       16,813  
Effect of dilutive securities:
                               
Stock options
    3,270       1,402       2,864       1,679  
 
   
     
     
     
 
Weighted average shares outstanding—diluted
    19,890       18,176       19,351       18,492  
 
   
     
     
     
 
Reported net income per share:
                               
Basic
  $ 0.15     $ 0.02     $ 0.23     $ 0.14  
 
   
     
     
     
 
Diluted
  $ 0.12     $ 0.02     $ 0.19     $ 0.13  
 
   
     
     
     
 

     Options to purchase 151,000 shares of common stock at a weighted average exercise price of $8.32 per share outstanding during the quarter ended January 31, 2004 and options to purchase 1,168,000 shares of common stock at a weighted average exercise price of $6.15 per share outstanding during the quarter ended January 31, 2003 were not included in the computation of diluted income per share because the inclusion of such options would have been antidilutive.

     Options to purchase 672,000 shares of common stock at a weighted average exercise price of $6.58 during the nine months ended January 31, 2004 and options to purchase 1,362,000 shares of common stock at a weighted average exercise price of $6.19 per share outstanding during the nine months ended January 31, 2003 were not included in the computation of diluted income per share because the inclusion of such options would have been antidilutive.

Note 3 – Other comprehensive Income:

     The components of other comprehensive income are presented in the following table (in thousands):

                                 
    Three Months Ended   Nine Months Ended
   
 
    January 31,   January 31,   January 31,   January 31,
    2004   2003   2004   2003
   
 
 
 
Reported net income
  $ 2,421     $ 314     $ 3,767     $ 2,317  
Other comprehensive income:
                               
Unrealized (losses) gains on available-for-sale investments
    12       10       (16 )     10